newsfilter
← Latest News
GlobeNewswire·

Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been